← All trials
NCT04860661
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2021
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Apr 27, 2021
- Last posted
- Apr 27, 2021
- Enrollment
- 1248
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Huazhong University of Science and TechnologyLead sponsor
- Anhui Medical UniversityCollaborator
- Hacettepe UniversityCollaborator
- Nanjing UniversityCollaborator
- Dalian Medical UniversityCollaborator
- Huazhong University of Science and TechnologySponsor investigator
- Central South UniversityCollaborator
- University of South ChinaCollaborator
- Maternal and Child Health Hospital of Hubei ProvinceCollaborator
- Guangdong Women and Children HospitalCollaborator
- Huazhong University of Science and TechnologyOverall official - principal investigator
- Zhengzhou UniversityCollaborator
- Shandong Jining No. 1 People's HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.